Real-time · AI · Cross-signal
Pillar Biosciences just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Pillar Biosciences, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Pillar Biosciences Partners with AstraZeneca to Accelerate Liquid Biopsy Testing
Sep 10, 2024•over 1 year ago
Contract Type
partnership
Description
Pillar Biosciences, Inc. has entered into a strategic partnership with AstraZeneca to expand laboratory access to molecular testing, using rapid, Next Generation Sequencing (NGS)-based liquid biopsy tumor profiling panels for detection of genetic cancer variants in European markets and the UK.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months